世界肝脏疾病的负担

IF 26.8 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY
Sumeet K. Asrani , Harshad Devarbhavi , John Eaton , Patrick S. Kamath
{"title":"世界肝脏疾病的负担","authors":"Sumeet K. Asrani ,&nbsp;Harshad Devarbhavi ,&nbsp;John Eaton ,&nbsp;Patrick S. Kamath","doi":"10.1016/j.jhep.2018.09.014","DOIUrl":null,"url":null,"abstract":"<div><p><span>Liver disease accounts for approximately 2 million deaths per year worldwide, 1 million due to complications of cirrhosis and 1</span> <span><span>million due to viral hepatitis<span> and hepatocellular carcinoma. Cirrhosis is currently the 11th most common cause of death globally and liver cancer is the 16th leading cause of death; combined, they account for 3.5% of all deaths worldwide. Cirrhosis is within the top 20 causes of disability-adjusted life years and years of life lost, accounting for 1.6% and 2.1% of the worldwide burden. About 2 billion people consume alcohol worldwide and upwards of 75 million are diagnosed with alcohol-use disorders and are at risk of alcohol-associated liver disease. Approximately 2 billion adults are obese or overweight and over 400 million have diabetes; both of which are risk factors for non-alcoholic fatty liver disease and hepatocellular carcinoma. The global prevalence of viral hepatitis remains high, while drug-induced liver injury continues to increase as a major cause of acute hepatitis. Liver transplantation<span> is the second most common solid organ transplantation, yet less than 10% of global transplantation needs are met at current rates. Though these numbers are sobering, they highlight an important opportunity to improve </span></span></span>public health given that most causes of liver diseases are preventable.</span></p></div>","PeriodicalId":15888,"journal":{"name":"Journal of Hepatology","volume":"70 1","pages":"Pages 151-171"},"PeriodicalIF":26.8000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.jhep.2018.09.014","citationCount":"1945","resultStr":"{\"title\":\"Burden of liver diseases in the world\",\"authors\":\"Sumeet K. Asrani ,&nbsp;Harshad Devarbhavi ,&nbsp;John Eaton ,&nbsp;Patrick S. Kamath\",\"doi\":\"10.1016/j.jhep.2018.09.014\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p><span>Liver disease accounts for approximately 2 million deaths per year worldwide, 1 million due to complications of cirrhosis and 1</span> <span><span>million due to viral hepatitis<span> and hepatocellular carcinoma. Cirrhosis is currently the 11th most common cause of death globally and liver cancer is the 16th leading cause of death; combined, they account for 3.5% of all deaths worldwide. Cirrhosis is within the top 20 causes of disability-adjusted life years and years of life lost, accounting for 1.6% and 2.1% of the worldwide burden. About 2 billion people consume alcohol worldwide and upwards of 75 million are diagnosed with alcohol-use disorders and are at risk of alcohol-associated liver disease. Approximately 2 billion adults are obese or overweight and over 400 million have diabetes; both of which are risk factors for non-alcoholic fatty liver disease and hepatocellular carcinoma. The global prevalence of viral hepatitis remains high, while drug-induced liver injury continues to increase as a major cause of acute hepatitis. Liver transplantation<span> is the second most common solid organ transplantation, yet less than 10% of global transplantation needs are met at current rates. Though these numbers are sobering, they highlight an important opportunity to improve </span></span></span>public health given that most causes of liver diseases are preventable.</span></p></div>\",\"PeriodicalId\":15888,\"journal\":{\"name\":\"Journal of Hepatology\",\"volume\":\"70 1\",\"pages\":\"Pages 151-171\"},\"PeriodicalIF\":26.8000,\"publicationDate\":\"2019-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/j.jhep.2018.09.014\",\"citationCount\":\"1945\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Hepatology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0168827818323882\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Hepatology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0168827818323882","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 1945

摘要

全世界每年约有200万人死于肝病,其中100万人死于肝硬化并发症,100万人死于病毒性肝炎和肝细胞癌。肝硬化目前是全球第11大最常见死亡原因,肝癌是第16大主要死亡原因;这些疾病加起来占全球死亡人数的3.5%。肝硬化是导致残疾调整生命年数和生命损失年数的前20大原因之一,分别占全球负担的1.6%和2.1%。全世界约有20亿人饮酒,超过7500万人被诊断患有酒精使用障碍,并面临酒精相关肝病的风险。大约20亿成年人肥胖或超重,超过4亿人患有糖尿病;这两者都是非酒精性脂肪性肝病和肝细胞癌的危险因素。病毒性肝炎的全球流行率仍然很高,而药物性肝损伤作为急性肝炎的主要原因继续增加。肝移植是第二大最常见的实体器官移植,但按照目前的速度,只有不到10%的全球移植需求得到满足。尽管这些数字发人深省,但它们强调了改善公共卫生的重要机会,因为大多数肝病的病因都是可以预防的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Burden of liver diseases in the world

Liver disease accounts for approximately 2 million deaths per year worldwide, 1 million due to complications of cirrhosis and 1 million due to viral hepatitis and hepatocellular carcinoma. Cirrhosis is currently the 11th most common cause of death globally and liver cancer is the 16th leading cause of death; combined, they account for 3.5% of all deaths worldwide. Cirrhosis is within the top 20 causes of disability-adjusted life years and years of life lost, accounting for 1.6% and 2.1% of the worldwide burden. About 2 billion people consume alcohol worldwide and upwards of 75 million are diagnosed with alcohol-use disorders and are at risk of alcohol-associated liver disease. Approximately 2 billion adults are obese or overweight and over 400 million have diabetes; both of which are risk factors for non-alcoholic fatty liver disease and hepatocellular carcinoma. The global prevalence of viral hepatitis remains high, while drug-induced liver injury continues to increase as a major cause of acute hepatitis. Liver transplantation is the second most common solid organ transplantation, yet less than 10% of global transplantation needs are met at current rates. Though these numbers are sobering, they highlight an important opportunity to improve public health given that most causes of liver diseases are preventable.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Journal of Hepatology
Journal of Hepatology 医学-胃肠肝病学
CiteScore
46.10
自引率
4.30%
发文量
2325
审稿时长
30 days
期刊介绍: The Journal of Hepatology is the official publication of the European Association for the Study of the Liver (EASL). It is dedicated to presenting clinical and basic research in the field of hepatology through original papers, reviews, case reports, and letters to the Editor. The Journal is published in English and may consider supplements that pass an editorial review.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信